| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/03/2005 | CN1649867A Novel 1, 2, 3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same |
| 08/03/2005 | CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 08/03/2005 | CN1649857A Hydroxamic acid derivatives |
| 08/03/2005 | CN1649849A Tachykinin receptor antagonists |
| 08/03/2005 | CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF) |
| 08/03/2005 | CN1649843A Novel chalcone derivatives and uses thereof |
| 08/03/2005 | CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 08/03/2005 | CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient |
| 08/03/2005 | CN1649624A Use of TNF alpha antibodies and another drug |
| 08/03/2005 | CN1649621A Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 08/03/2005 | CN1649611A Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| 08/03/2005 | CN1649597A Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
| 08/03/2005 | CN1649595A Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 08/03/2005 | CN1649593A Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 08/03/2005 | CN1649588A New pharmaceutical compositions based on anticholinergics and PED-IV inhibitors |
| 08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
| 08/03/2005 | CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 08/03/2005 | CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| 08/03/2005 | CN1649568A Pharmaceutical compositions for the treatment of asthma |
| 08/03/2005 | CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 08/03/2005 | CN1648249A Small molecular interference ribonucleic acid for inhibiting SARS virus gene expression |
| 08/03/2005 | CN1647823A Sars冠状病毒全病毒疫苗 Sars coronavirus whole virus vaccine |
| 08/03/2005 | CN1647795A Fatty acyl acetaldehyde transfusion preparation and its preparing method |
| 08/03/2005 | CN1647794A Fatty acyl acetaldehyde powder projection and its preparing method |
| 08/03/2005 | CN1213047C Puring derivatives inhibitors of tyrosine kinase SYK |
| 08/03/2005 | CN1213040C Serine protese inhibitors |
| 08/03/2005 | CN1213025C 硫代酰胺衍生物 Thioamide derivatives |
| 08/03/2005 | CN1213020C Phenylalaninol derivatives |
| 08/03/2005 | CN1212856C Medicine composition for treating sphagitis and preparing method thereof |
| 08/03/2005 | CN1212831C Pharmaceutical preparations |
| 08/02/2005 | US6924388 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 08/02/2005 | US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases |
| 08/02/2005 | US6924305 Diazocine derivatives and their use as tryptase inhibitors |
| 08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
| 08/02/2005 | US6924292 Nitrogen compounds such as 2-(methylsulfinyl) N [3-(3,4,8,9-tetrahydro-6-methoxy-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)phenyl]acetamide, used as phosphodiesterase inhibitors; antidiabetics; antiinflammatory agents |
| 08/02/2005 | US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 08/02/2005 | US6924288 Enantiomerically pure opioid diarylmethylpiperzine and methods of using same |
| 08/02/2005 | US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
| 08/02/2005 | US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| 08/02/2005 | US6923178 Medicament container with same side airflow inlet and outlet |
| 08/02/2005 | CA2362339C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/02/2005 | CA2362337C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/02/2005 | CA2165824C Use of modafinil for the treatment of sleep apnea and ventilation problems of central origin |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165087 Nf-kb inhibitors |
| 07/28/2005 | US20050165086 Aminothiophene inhibitors of NF- kappa B inhibitors for treatment of diseases such as cancer or aids |
| 07/28/2005 | US20050165064 Novel thiol derivative, process for producing the same and use thereof |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165056 salt formation; polymorph forms or amorphous forms; antihistamines, antiallergens, bronchodilator agent |
| 07/28/2005 | US20050165055 Novel substituted indoles |
| 07/28/2005 | US20050165041 Combination for the treatment of airway disorders |
| 07/28/2005 | US20050165033 mediated by prostaglandin D2, a ligand for orphan receptor CRTH2; rhinitis; N-substituted by a benzothiazolyl, a pyrimidinyl, an imidazolyl, an oxazolyl, or a thiazolyl |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165014 1 4-dihydro-1 4-diphenylpyridine derivatives |
| 07/28/2005 | US20050165011 6-[5-(6-methyl-pyridin-2-yl)-1H-[1,2,3]triazol-4-yl]-4H-benzo[1,4]oxazin-3-one, used as inhibitors of the transforming growth factor beta-signalling pathways, in particular, the phosphorylation of smad gene and proteins or activin-like kinase receptors; prophylaxis of kidney fibrosis |
| 07/28/2005 | US20050164997 a 3-oxo-androstancarbothioic acid compound; respiaratory system disorder |
| 07/28/2005 | US20050164995 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 07/28/2005 | US20050164993 Methods of treating allergic reactions |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164926 Novel recombinant anticoagulant proteins |
| 07/28/2005 | US20050164305 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 07/28/2005 | US20050164298 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor(ghs) |
| 07/28/2005 | US20050163767 useful as a diagnostic marker or a drug target for bronchial asthma, chronic obstructive pulmonary disease; isolated antibody which specifically binds to a specific protein belonging to the chitinase family |
| 07/28/2005 | US20050163727 Topical, oral administration; mouthrinses; microbiocides; bactericides; prevents spread of pathogenic oral bacteria, toxins and endotoxins, and resultant inflammatory cytokines and mediators; cardiovascular disease, stroke, atherosclerosis |
| 07/28/2005 | US20050163724 Contains steroidal anti-inflammatory drug, carrier (saccharides, sugar alcohols, amino acids), and water |
| 07/28/2005 | US20050163720 May be used to prepare novel aerosol formulations, and can be advantageous in terms of improving the stability of the aerosol formulation, reducing drug deposition, increasing shelf life |
| 07/28/2005 | DE202005004660U1 Medicinal product useful for treating airway diseases comprises a unit dose of a dry powder mixture of tiotropium and a carrier in a moisture-impermeable container suitable for use in an inhaler |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/28/2005 | CA2552540A1 Use of substituted pteridines for the treatment of diseases of the respiratory tract |
| 07/28/2005 | CA2552539A1 Use of substituted pyrimido[5,4-d]pyrimidines for the treatment of respiratory diseases |
| 07/28/2005 | CA2547394A1 New pharmaceutical compositions based on a scopineester and nicotinamide derivatives |
| 07/27/2005 | EP1557409A1 5HT2C receptor modulators |
| 07/27/2005 | EP1557172A1 Method and composition for regulating the activity of regulatory t cells |
| 07/27/2005 | EP1557164A1 Adhesive patch containing tulobuterol |
| 07/27/2005 | EP1557163A1 Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556371A2 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 07/27/2005 | EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556342A1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 07/27/2005 | EP1556340A1 Phenylethanolamine derivatives for the treatment of respiratory diseases |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy |
| 07/27/2005 | EP1556049A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1377573B1 Pyrazolopyridine derivatives |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1283709B1 Peptide deformylase inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | EP1237877B1 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 07/27/2005 | EP1107733B1 Oral liquid mucoadhesive compositions |
| 07/27/2005 | CN1646684A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 07/27/2005 | CN1646538A Topiramate salts and compositions comprising and methods of making and using the same |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646531A Thioxanthine derivatives as myeloperoxidase inhibitors |
| 07/27/2005 | CN1646529A Imidazo fused compounds |